HARMONY BIOSCIENCES HLDGS IN shareholders Q4 2022

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.

HARMONY BIOSCIENCES HLDGS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
Lisanti Capital Growth, LLC 193,830$10,680,0331.46%
Rhenman & Partners Asset Management AB 240,000$13,224,0001.38%
Paradiem, LLC 55,537$3,060,0891.13%
Penn Capital Management Company, LLC 175,987$9,709,5560.99%
Zebra Capital Management LLC 4,414$2430.85%
Tributary Capital Management, LLC 128,425$7,0760.70%
Quantedge Capital Pte Ltd 35,900$1,978,0900.66%
Perceptive Advisors 411,804$22,690,4000.64%
Sheets Smith Investment Management 11,367$544,1380.60%
Hood River Capital Management LLC 293,867$16,192,0720.59%
External links

This page lists HARMONY BIOSCIENCES HLDGS IN's shareholders in Q4 2022. To view HARMONY BIOSCIENCES HLDGS IN's shareholder history, click here.